Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

David Brooks

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Parkinson Disease

Anatomy

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Edison Paul; Brooks David J; Turkheimer Federico E; Archer Hilary A; Hinz Rainer
Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility.
Williams Tim M; Davies Simon J C; Taylor Lindsay G; Daglish Mark R C; Hammers Alexander; Brooks David J; Nutt David J; Lingford-Hughes Anne
Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study.
Okello A; Koivunen J; Edison P; Archer H A; Turkheimer F E; Någren K; Bullock R; Walker Z; Kennedy A; Fox N C; Rossor M N; Rinne J O; Brooks D J
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of David Brooks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Edison Paul; Brooks David J; Turkheimer Federico E; Archer Hilary A; Hinz Rainer
Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility.
NeuroImage 2009;48(2):329-38.
2009: Williams Tim M; Davies Simon J C; Taylor Lindsay G; Daglish Mark R C; Hammers Alexander; Brooks David J; Nutt David J; Lingford-Hughes Anne
Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(10):740-8.
2009: Okello A; Koivunen J; Edison P; Archer H A; Turkheimer F E; Någren K; Bullock R; Walker Z; Kennedy A; Fox N C; Rossor M N; Rinne J O; Brooks D J
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.
Neurology 2009;73(10):754-60.
2009: Nelissen Natalie; Van Laere Koen; Thurfjell Lennart; Owenius Rikard; Vandenbulcke Mathieu; Koole Michel; Bormans Guy; Brooks David J; Vandenberghe Rik
Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(8):1251-9.
2009: Pavese Nicola; Brooks David J
Imaging neurodegeneration in Parkinson's disease.
Biochimica et biophysica acta 2009;1792(7):722-9.
2009: Koole Michel; Lewis Dewi M; Buckley Christopher; Nelissen Natalie; Vandenbulcke Mathieu; Brooks David J; Vandenberghe Rik; Van Laere Koen
Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(5):818-22.
2009: Brooks David J; Seppi Klaus;
Proposed neuroimaging criteria for the diagnosis of multiple system atrophy.
Movement disorders : official journal of the Movement Disorder Society 2009;24(7):949-64.
2009: Giladi Nir; Tal Joseph; Azulay Tali; Rascol Oliver; Brooks David J; Melamed Eldad; Oertel Wolfgang; Poewe Werner H; Stocchi Fabrizio; Tolosa Eduardo
Validation of the freezing of gait questionnaire in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(5):655-61.
2009: Okello A; Edison P; Archer H A; Turkheimer F E; Kennedy J; Bullock R; Walker Z; Kennedy A; Fox N; Rossor M; Brooks D J
Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.
Neurology 2009;72(1):56-62.
2008: Edison Paul; Archer Hilary A; Gerhard Alexander; Hinz Rainer; Pavese Nicola; Turkheimer Federico E; Hammers Alexander; Tai Yen Fong; Fox Nick; Kennedy Angus; Rossor Martin; Brooks David J
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.
Neurobiology of disease 2008;32(3):412-9.
2008: Edison P; Rowe C C; Rinne J O; Ng S; Ahmed I; Kemppainen N; Villemagne V L; O'Keefe G; Någren K; Chaudhury K R; Masters C L; Brooks D J
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
Journal of neurology, neurosurgery, and psychiatry 2008;79(12):1331-8.
2008: Brooks David J
The role of structural and functional imaging in parkinsonian states with a description of PET technology.
Seminars in neurology 2008;28(4):435-45.
2008: Brooks D J; Doder M; Osman S; Luthra S K; Hirani E; Hume S; Kase H; Kilborn J; Martindill S; Mori A
Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain.
Synapse (New York, N.Y.) 2008;62(9):671-81.
2008: Gilman S; Wenning G K; Low P A; Brooks D J; Mathias C J; Trojanowski J Q; Wood N W; Colosimo C; Dürr A; Fowler C J; Kaufmann H; Klockgether T; Lees A; Poewe W; Quinn N; Revesz T; Robertson D; Sandroni P; Seppi K; Vidailhet M
Second consensus statement on the diagnosis of multiple system atrophy.
Neurology 2008;71(9):670-6.
2008: Tomasi Giampaolo; Edison Paul; Bertoldo Alessandra; Roncaroli Federico; Singh Poonam; Gerhard Alexander; Cobelli Claudio; Brooks David J; Turkheimer Federico E
Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(8):1249-56.
2008: Reuter I; Tai Y F; Pavese N; Chaudhuri K R; Mason S; Polkey C E; Clough C; Brooks D J; Barker R A; Piccini P
Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.
Journal of neurology, neurosurgery, and psychiatry 2008;79(8):948-51.
2008: Daglish Mark R C; Williams Tim M; Wilson Sue J; Taylor Lindsay G; Eap Chin B; Augsburger Marc; Giroud Christian; Brooks David J; Myles Judy S; Grasby Paul; Lingford-Hughes Anne R; Nutt David J
Brain dopamine response in human opioid addiction.
The British journal of psychiatry : the journal of mental science 2008;193(1):65-72.
2008: Brooks David J; Leinonen Mika; Kuoppamäki Mikko; Nissinen Helena
Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(6):843-9.
2008: Brooks David J;
Technology insight: imaging neurodegeneration in Parkinson's disease.
Nature clinical practice. Neurology 2008;4(5):267-77.
2008: Sawamoto Nobukatsu; Piccini Paola; Hotton Gary; Pavese Nicola; Thielemans Kris; Brooks David J
Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.
Brain : a journal of neurology 2008;131(Pt 5):1294-302.
2008: Klinge Petra M; Brooks David J; Samii Amir; Weckesser Eva; van den Hoff Jörg; Fricke Harald; Brinker Thomas; Knapp Wolfram H; Berding Georg
Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting--A retrospective analysis of [(15)O]H(2)O PET-CBF studies in 65 patients.
Clinical neurology and neurosurgery 2008;110(4):369-75.
2008: Moore Robert Y; Whone Alan L; Brooks David J
Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study.
Neurobiology of disease 2008;29(3):381-90.
2008: Brooks David J
Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective.
Neuropsychiatric disease and treatment 2008;4(1):39-47.
2008: Wicks Paul; Turner Martin R; Abrahams Sharon; Hammers Alexander; Brooks David J; Leigh P Nigel; Goldstein Laura H
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2008;9(1):43-9.
2008: Hammers Alexander; Panagoda Prasan; Heckemann Rolf A; Kelsch Wolfgang; Turkheimer Federico E; Brooks David J; Duncan John S; Koepp Matthias J
[11C]Flumazenil PET in temporal lobe epilepsy: do we need an arterial input function or kinetic modeling?
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2008;28(1):207-16.
2007: Turner Martin R; Hammers Alexander; Allsop Joanna; Al-Chalabi Ammar; Shaw Christopher E; Brooks David J; Leigh P Nigel; Andersen Peter M
Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2007;8(6):343-7.
2007: Ahsan R Laila; Allom Richard; Gousias Ioannis S; Habib Helai; Turkheimer Federico E; Free Samantha; Lemieux Louis; Myers Ralph; Duncan John S; Brooks David J; Koepp Matthias J; Hammers Alexander
Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus.
NeuroImage 2007;38(2):261-70.
2007: Hammers Alexander; Asselin Marie-Claude; Turkheimer Federico E; Hinz Rainer; Osman Safiye; Hotton Gary; Brooks David J; Duncan John S; Koepp Matthias J
Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [(11)C]diprenorphine test-retest data.
NeuroImage 2007;38(1):82-94.
2007: Turner Martin R; Hammers Alexander; Al-Chalabi Ammar; Shaw Christopher E; Andersen Peter M; Brooks David J; Leigh P Nigel
Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.
Journal of neurology 2007;254(8):1033-6.
2007: Mínguez-Castellanos Adolfo; Escamilla-Sevilla Francisco; Hotton Gary R; Toledo-Aral Juan J; Ortega-Moreno Angel; Méndez-Ferrer Simón; Martín-Linares José M; Katati Majed J; Mir Pablo; Villadiego Javier; Meersmans Miguel; Pérez-García Miguel; Brooks David J; Arjona Ventura; López-Barneo José
Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study.
Journal of neurology, neurosurgery, and psychiatry 2007;78(8):825-31.
2007: Williams Tim M; Daglish Mark R C; Lingford-Hughes Anne; Taylor Lindsay G; Hammers Alexander; Brooks David J; Grasby Paul; Myles Judith S; Nutt David J
Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography study.
The British journal of psychiatry : the journal of mental science 2007;191():63-9.
2007: Tai Yen F; Pavese Nicola; Gerhard Alexander; Tabrizi Sarah J; Barker Roger A; Brooks David J; Piccini Paola
Microglial activation in presymptomatic Huntington's disease gene carriers.
Brain : a journal of neurology 2007;130(Pt 7):1759-66.
2007: Brooks David J
Imaging non-dopaminergic function in Parkinson's disease.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2007;9(4):217-22.
2007: Thobois Stéphane; Hotton Gary R; Pinto Serge; Wilkinson Leonora; Limousin-Dowsey Patricia; Brooks David J; Jahanshahi Marjan
STN stimulation alters pallidal-frontal coupling during response selection under competition.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2007;27(6):1173-84.
2007: Anderson Alexander N; Pavese Nicola; Edison Paul; Tai Yan F; Hammers Alexander; Gerhard Alexander; Brooks David J; Turkheimer Federico E
A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195.
NeuroImage 2007;36(1):28-37.
2007: Turner M R; Rabiner E A; Al-Chalabi A; Shaw C E; Brooks D J; Leigh P N; Andersen P M
Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS.
Neurology 2007;68(15):1233-5.
2007: Tai Yen F; Pavese Nicola; Gerhard Alexander; Tabrizi Sarah J; Barker Roger A; Brooks David J; Piccini Paola
Imaging microglial activation in Huntington's disease.
Brain research bulletin 2007;72(2-3):148-51.
2007: Hammers Alexander; Asselin Marie-Claude; Hinz Rainer; Kitchen Ian; Brooks David J; Duncan John S; Koepp Matthias J
Upregulation of opioid receptor binding following spontaneous epileptic seizures.
Brain : a journal of neurology 2007;130(Pt 4):1009-16.
2007: Lippa C F; Duda J E; Grossman M; Hurtig H I; Aarsland D; Boeve B F; Brooks D J; Dickson D W; Dubois B; Emre M; Fahn S; Farmer J M; Galasko D; Galvin J E; Goetz C G; Growdon J H; Gwinn-Hardy K A; Hardy J; Heutink P; Iwatsubo T; Kosaka K; Lee V M-Y; Leverenz J B; Masliah E; McKeith I G; Nussbaum R L; Olanow C W; Ravina B M; Singleton A B; Tanner C M; Trojanowski J Q; Wszolek Z K;
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.
Neurology 2007;68(11):812-9.
2007: Tai Y F; Ahsan R L; de Yébenes J G; Pavese N; Brooks D J; Piccini P
Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an 18F-dopa PET study.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(3):337-40.
2007: Edison P; Archer H A; Hinz R; Hammers A; Pavese N; Tai Y F; Hotton G; Cutler D; Fox N; Kennedy A; Rossor M; Brooks D J
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
Neurology 2007;68(7):501-8.
2007: Turkheimer Federico E; Edison Paul; Pavese Nicola; Roncaroli Federico; Anderson Alexander N; Hammers Alexander; Gerhard Alexander; Hinz Rainer; Tai Yan F; Brooks David J
Reference and target region modeling of [11C]-(R)-PK11195 brain studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(1):158-67.
2007: Lawrence Andrew D; Goerendt Ines K; Brooks David J
Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy.
Neuropsychologia 2007;45(1):65-74.
2007: Hammers Alexander; Chen Chi-Hua; Lemieux Louis; Allom Richard; Vossos Spyridon; Free Samantha L; Myers Ralph; Brooks David J; Duncan John S; Koepp Matthias J
Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space.
Human brain mapping 2007;28(1):34-48.
2007: Brooks David J
Imaging Parkinson's disease.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;83():245-63.
2007: Brooks David J
Assessment of Parkinson's disease with imaging.
Parkinsonism & related disorders 2007;13 Suppl 3():S268-75.
2006: Piccini Paola; Brooks David J
New developments of brain imaging for Parkinson's disease and related disorders.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2035-41.
2006: Pavese N; Evans A H; Tai Y F; Hotton G; Brooks D J; Lees A J; Piccini P
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study.
Neurology 2006;67(9):1612-7.
2006: Rascol Olivier; Brooks David J; Korczyn Amos D; De Deyn Peter P; Clarke Carl E; Lang Anthony E; Abdalla Mona;
Development of dyskinesias in a 5-year trial of ropinirole and L-dopa.
Movement disorders : official journal of the Movement Disorder Society 2006;21(11):1844-50.
2006: Brooks David J
Imaging the role of dopamine in health and disease Parkinson's disease as a lesion model.
Wiener klinische Wochenschrift 2006;118(19-20):570-2.
2006: Brooks David J
Dopaminergic action beyond its effects on motor function: imaging studies.
Journal of neurology 2006;253 Suppl 4():IV8-15.
2006: Archer Hilary A; Edison Paul; Brooks David J; Barnes Jo; Frost Chris; Yeatman Tom; Fox Nick C; Rossor Martin N
Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.
Annals of neurology 2006;60(1):145-7.
2006: Pavese N; Gerhard A; Tai Y F; Ho A K; Turkheimer F; Barker R A; Brooks D J; Piccini P
Microglial activation correlates with severity in Huntington disease: a clinical and PET study.
Neurology 2006;66(11):1638-43.
2006: Scherfler Christoph; Khan Naheed L; Pavese Nicola; Lees Andrew J; Quinn Niall P; Brooks David J; Piccini Paola P
Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.
Movement disorders : official journal of the Movement Disorder Society 2006;21(6):783-8.
2006: Brooks David J; Piccini Paola
Imaging in Parkinson's disease: the role of monoamines in behavior.
Biological psychiatry 2006;59(10):908-18.
2006: Evans Andrew H; Pavese Nicola; Lawrence Andrew D; Tai Yen F; Appel Silke; Doder Miroslava; Brooks David J; Lees Andrew J; Piccini Paola
Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Annals of neurology 2006;59(5):852-8.
2006: Lang Anthony E; Langston J William; Stoessl A Jon; Brodsky Matthew; Brooks David J; Dhawan Vijay; Elias William J; Lozano Andres M; Moro Elena; Nutt John G; Stacy Mark; Turner Dennis; Wooten G Frederick
GDNF in treatment of Parkinson's disease: response to editorial.
Lancet neurology 2006;5(3):200-2.
2006: Lang Anthony E; Gill Steven; Patel Nik K; Lozano Andres; Nutt John G; Penn Richard; Brooks David J; Hotton Gary; Moro Elena; Heywood Peter; Brodsky Matthew A; Burchiel Kim; Kelly Patrick; Dalvi Arif; Scott Burton; Stacy Mark; Turner Dennis; Wooten V G Frederich; Elias William J; Laws Edward R; Dhawan Vijay; Stoessl A Jon; Matcham James; Coffey Robert J; Traub Michael
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Annals of neurology 2006;59(3):459-66.
2006: Hu Michele T M; Scherfler Christoph; Khan Naheed L; Hajnal Jo V; Lees Andrew J; Quinn Niall; Wood Nicholas W; Brooks David J
Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2006;21(3):299-305.
2006: Gerhard Alexander; Pavese Nicola; Hotton Gary; Turkheimer Federico; Es Meltem; Hammers Alexander; Eggert Karla; Oertel Wolfgang; Banati Richard B; Brooks David J
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Neurobiology of disease 2006;21(2):404-12.
2006: Gerhard Alexander; Trender-Gerhard Iris; Turkheimer Federico; Quinn Niall P; Bhatia Kailash P; Brooks David J
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):89-93.
2006: Goerendt I K; Lawrence A D; Mehta M A; Stern J S; Odin P; Brooks D J
Distributed neural actions of anti-parkinsonian therapies as revealed by PET.
Journal of neural transmission (Vienna, Austria : 1996) 2006;113(1):75-86.
2006: Brooks Daniel J; Vosburg Suzanne K; Evans Suzette M; Levin Frances R
Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence.
Journal of addictive diseases 2006;25(4):15-25.
2005: Khan Naheed L; Jain Shushant; Lynch John M; Pavese Nicola; Abou-Sleiman Patrick; Holton Janice L; Healy Daniel G; Gilks William P; Sweeney Mary G; Ganguly Milan; Gibbons Vaneesha; Gandhi Sonia; Vaughan Jenny; Eunson Louise H; Katzenschlager Regina; Gayton Juliet; Lennox Graham; Revesz Tamas; Nicholl David; Bhatia Kailash P; Quinn Niall; Brooks David; Lees Andrew J; Davis Mary B; Piccini Paola; Singleton Andrew B; Wood Nicholas W
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.
Brain : a journal of neurology 2005;128(Pt 12):2786-96.
2005: Piccini Paola; Pavese Nicola; Hagell Peter; Reimer Jan; Björklund Anders; Oertel Wolfgang H; Quinn Niall P; Brooks David J; Lindvall Olle
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.
Brain : a journal of neurology 2005;128(Pt 12):2977-86.
2005: Isaacs Jeremy D; Rakshi James; Baker Richard; Brooks David J; Warrens Anthony N
Chorea associated with thyroxine replacement therapy.
Movement disorders : official journal of the Movement Disorder Society 2005;20(12):1656-7.
2005: Brooks David J; Douthwaite Richard E; Gillie Lisa J
Plasma-promoted dielectric heating in the microwave synthesis of spinels.
Chemical communications (Cambridge, England) 2005;(38):4857-9.
2005: Turner M R; Osei-Lah A D; Hammers A; Al-Chalabi A; Shaw C E; Andersen P M; Brooks D J; Leigh P N; Mills K R
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.
Journal of neurology, neurosurgery, and psychiatry 2005;76(9):1279-85.
2005: Cheesman A L; Barker R A; Lewis S J G; Robbins T W; Owen A M; Brooks D J
Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2005;76(9):1204-10.
2005: Lingford-Hughes A R; Wilson S J; Cunningham V J; Feeney A; Stevenson B; Brooks D J; Nutt D J
GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study.
Psychopharmacology 2005;180(4):595-606.
2005: Love Seth; Plaha Puneet; Patel Nikunj K; Hotton Gary R; Brooks David J; Gill Steven S
Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain.
Nature medicine 2005;11(7):703-4.
2005: Hammers Alexander; Koepp Matthias J; Brooks David J; Duncan John S
Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis.
Epilepsia 2005;46(6):944-8.
2005: Turner M R; Gerhard A; Al-Chalabi A; Shaw C E; Hughes R A C; Banati R B; Brooks D J; Leigh P N
Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET.
Journal of neurology, neurosurgery, and psychiatry 2005;76(6):871-4.
2005: Turner M R; Hammers A; Al-Chalabi A; Shaw C E; Andersen P M; Brooks D J; Leigh P N
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.
Brain : a journal of neurology 2005;128(Pt 6):1323-9.
2005: Remy Philippe; Doder Miroslava; Lees Andrew; Turjanski Nora; Brooks David
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.
Brain : a journal of neurology 2005;128(Pt 6):1314-22.
2005: Ros Raquel; Gómez Garre Pilar; Hirano Michio; Tai Yen F; Ampuero Israel; Vidal Lídice; Rojo Ana; Fontan Aurora; Vazquez Ana; Fanjul Samira; Hernandez Jaime; Cantarero Susana; Hoenicka Janet; Jones Alison; Ahsan R Laila; Pavese Nicola; Piccini Paola; Brooks David J; Perez-Tur Jordi; Nyggard Torbjorn; de Yébenes Justo G
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1.
Annals of neurology 2005;57(5):634-41.
2005: Brooks David J
Positron emission tomography and single-photon emission computed tomography in central nervous system drug development.
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2005;2(2):226-36.
2005: von Spiczak Sarah; Whone Alan L; Hammers Alexander; Asselin Marie-Claude; Turkheimer Federico; Tings Tobias; Happe Svenja; Paulus Walter; Trenkwalder Claudia; Brooks David J
The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study.
Brain : a journal of neurology 2005;128(Pt 4):906-17.
2005: Turner M R; Rabiner E A; Hammers A; Al-Chalabi A; Grasby P M; Shaw C E; Brooks D J; Leigh P N
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.
Brain : a journal of neurology 2005;128(Pt 4):896-905.
2005: Rascol O; Brooks D J; Melamed E; Oertel W; Poewe W; Stocchi F; Tolosa E;
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
Lancet 2005;365(9463):947-54.
2005: Ravina B; Eidelberg D; Ahlskog J E; Albin R L; Brooks D J; Carbon M; Dhawan V; Feigin A; Fahn S; Guttman M; Gwinn-Hardy K; McFarland H; Innis R; Katz R G; Kieburtz K; Kish S J; Lange N; Langston J W; Marek K; Morin L; Moy C; Murphy D; Oertel W H; Oliver G; Palesch Y; Powers W; Seibyl J; Sethi K D; Shults C W; Sheehy P; Stoessl A J; Holloway R
The role of radiotracer imaging in Parkinson disease.
Neurology 2005;64(2):208-15.
2005: Khan N L; Scherfler C; Graham E; Bhatia K P; Quinn N; Lees A J; Brooks D J; Wood N W; Piccini P
Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
Neurology 2005;64(1):134-6.
2005: Chaudhuri K Ray; Buxton-Thomas M; Dhawan V; Peng R; Meilak C; Brooks D J
Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases.
Journal of neurology, neurosurgery, and psychiatry 2005;76(1):115-7.
2005: Melichar Jan K; Hume Susan P; Williams Tim M; Daglish Mark R C; Taylor Lindsay G; Ahmad Rabia; Malizia Andrea L; Brooks David J; Myles Judith S; Lingford-Hughes Anne; Nutt David J
Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: clinical and preclinical studies.
The Journal of pharmacology and experimental therapeutics 2005;312(1):309-15.
2005: Brooks D J; Agid Y; Eggert K; Widner H; Ostergaard K; Holopainen A;
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
European neurology 2005;53(4):197-202.
2004: Whone Alan L; Von Spiczak Sarah; Edwards Mark; Valente Enza-Maria; Hammers Alexander; Bhatia Kailash P; Brooks David J
Opioid binding in DYT1 primary torsion dystonia: an 11C-diprenorphine PET study.
Movement disorders : official journal of the Movement Disorder Society 2004;19(12):1498-503.
2004: Brooks David J
Positron emission tomography imaging of transplant function.
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2004;1(4):482-91.
2004: Gerhard Alexander; Watts Justin; Trender-Gerhard Iris; Turkheimer Federico; Banati Richard B; Bhatia Kailash; Brooks David J
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration.
Movement disorders : official journal of the Movement Disorder Society 2004;19(10):1221-6.
2004: Whone Alan L; Bailey Dale L; Remy Philippe; Pavese Nicola; Brooks David J
A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1135-45.
2004: Scherfler Christoph; Khan Naheed L; Pavese Nicola; Eunson Louise; Graham Elizabeth; Lees Andrew J; Quinn Niall P; Wood Nicholas W; Brooks David J; Piccini Paola P
Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
Brain : a journal of neurology 2004;127(Pt 6):1332-42.
2004: Berding Georg; Müller-Vahl Kirsten; Schneider Udo; Gielow Peter; Fitschen Jürgen; Stuhrmann Manfred; Harke Heinrich; Buchert Ralph; Donnerstag Frank; Hofmann Michael; Knoop Bernd O; Brooks David J; Emrich Hinderk M; Knapp Wolfram H
[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients.
Biological psychiatry 2004;55(9):904-15.
2004: Brooks David J
Neuroimaging in Parkinson's disease.
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2004;1(2):243-54.
2004: Turner M R; Cagnin A; Turkheimer F E; Miller C C J; Shaw C E; Brooks D J; Leigh P N; Banati R B
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.
Neurobiology of disease 2004;15(3):601-9.
2004: Pavese Nicola; Rimoldi Ornella; Gerhard Alexander; Brooks David J; Piccini Paola
Cardiovascular effects of methamphetamine in Parkinson's disease patients.
Movement disorders : official journal of the Movement Disorder Society 2004;19(3):298-303.
2004: Tai Yen F; Scherfler Christoph; Brooks David J; Sawamoto Nobukatsu; Castiello Umberto
The human premotor cortex is 'mirror' only for biological actions.
Current biology : CB 2004;14(2):117-20.
2004: Brooks David J
Safety and tolerability of COMT inhibitors.
Neurology 2004;62(1 Suppl 1):S39-46.
2004: Goerendt Ines K; Lawrence Andrew D; Brooks David J
Reward processing in health and Parkinson's disease: neural organization and reorganization.
Cerebral cortex (New York, N.Y. : 1991) 2004;14(1):73-80.
2004: Fern-Pollak Liory; Whone Alan L; Brooks David J; Mehta Mitul A
Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
Neuropsychologia 2004;42(14):1917-26.
2003: Brooks D J; Frey K A; Marek K L; Oakes D; Paty D; Prentice R; Shults C W; Stoessl A J
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Experimental neurology 2003;184 Suppl 1():S68-79.
2003: Gerhard A; Banati R B; Goerres G B; Cagnin A; Myers R; Gunn R N; Turkheimer F; Good C D; Mathias C J; Quinn N; Schwarz J; Brooks D J
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.
Neurology 2003;61(5):686-9.
2003: Moore Robert Y; Whone Alan L; McGowan Stephen; Brooks David J
Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.
Brain research 2003;982(2):137-45.
2003: Brooks D J; Sagar H;
Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study.
Journal of neurology, neurosurgery, and psychiatry 2003;74(8):1071-9.
2003: Hammers Alexander; Allom Richard; Koepp Matthias J; Free Samantha L; Myers Ralph; Lemieux Louis; Mitchell Tejal N; Brooks David J; Duncan John S
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe.
Human brain mapping 2003;19(4):224-47.
2003: Whone Alan L; Watts Ray L; Stoessl A Jon; Davis Margaret; Reske Sven; Nahmias Claude; Lang Anthony E; Rascol Olivier; Ribeiro Maria J; Remy Philippe; Poewe Werner H; Hauser Robert A; Brooks David J;
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Annals of neurology 2003;54(1):93-101.
2003: Brooks David J
PET studies on the function of dopamine in health and Parkinson's disease.
Annals of the New York Academy of Sciences 2003;991():22-35.
2003: Hammers Alexander; Koepp Matthias J; Richardson Mark P; Hurlemann René; Brooks David J; Duncan John S
Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients.
Brain : a journal of neurology 2003;126(Pt 6):1300-18.
2003: Piccini Paola; Pavese Nicola; Brooks David J
Endogenous dopamine release after pharmacological challenges in Parkinson's disease.
Annals of neurology 2003;53(5):647-53.
2003: Pavese Nicola; Andrews Thomasin C; Brooks David J; Ho Aileen K; Rosser Anne E; Barker Roger A; Robbins Trevor W; Sahakian Barbara J; Dunnett Stephen B; Piccini Paola
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study.
Brain : a journal of neurology 2003;126(Pt 5):1127-35.
2003: Gill Steven S; Patel Nikunj K; Hotton Gary R; O'Sullivan Karen; McCarter Renée; Bunnage Martin; Brooks David J; Svendsen Clive N; Heywood Peter
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
Nature medicine 2003;9(5):589-95.
2003: Berding G; Brücke Th; Odin P; Brooks D J; Kolbe H; Gielow P; Harke H; Knoop B O; Dengler R; Knapp W H
[[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
Nuklearmedizin. Nuclear medicine 2003;42(1):31-8.
2003: Doder M; Rabiner E A; Turjanski N; Lees A J; Brooks D J;
Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study.
Neurology 2003;60(4):601-5.
2003: Whone Alan L; Moore Robert Y; Piccini Paola P; Brooks David J
Plasticity of the nigropallidal pathway in Parkinson's disease.
Annals of neurology 2003;53(2):206-13.
2003: Goerendt Ines K; Messa Cristina; Lawrence Andrew D; Grasby Paul M; Piccini Paola; Brooks David J;
Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study.
Brain : a journal of neurology 2003;126(Pt 2):312-25.
2003: Brooks David J
Imaging end points for monitoring neuroprotection in Parkinson's disease.
Annals of neurology 2003;53 Suppl 3():S110-8; discussion S118-9.
2002: Rakshi J S; Pavese N; Uema T; Ito K; Morrish P K; Bailey D L; Brooks D J
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(12):1433-43.
2002: Khan Naheed L; Valente Enza Maria; Bentivoglio Anna Rita; Wood Nicholas W; Albanese Alberto; Brooks David J; Piccini Paola
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study.
Annals of neurology 2002;52(6):849-53.
2002: Hu Michele T M; Chaudhuri K Ray; Jarosz Jozef; Yaguez Lidia; Brooks David J
An imaging study of parkinsonism among African-Caribbean and Indian London communities.
Movement disorders : official journal of the Movement Disorder Society 2002;17(6):1321-8.
2002: Boecker H; Ceballos-Baumann A O; Bartenstein P; Dagher A; Forster K; Haslinger B; Brooks D J; Schwaiger M; Conrad B
A H(2)(15)O positron emission tomography study on mental imagery of movement sequences--the effect of modulating sequence length and direction.
NeuroImage 2002;17(2):999-1009.
2002: Hammers A; Koepp M J; Hurlemann R; Thom M; Richardson M P; Brooks D J; Duncan J S
Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI.
Brain : a journal of neurology 2002;125(Pt 10):2257-71.
2002: Khan Naheed L; Brooks David J; Pavese Nicola; Sweeney Mary G; Wood Nicholas W; Lees Andrew J; Piccini Paola
Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study.
Brain : a journal of neurology 2002;125(Pt 10):2248-56.
2002: Lingford-Hughes Anne; Hume Susan P; Feeney Adrian; Hirani Ella; Osman Safiye; Cunningham Vincent J; Pike Victor W; Brooks David J; Nutt David J
Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2002;22(7):878-89.
2002: Hagell Peter; Piccini Paola; Björklund Anders; Brundin Patrik; Rehncrona Stig; Widner Håkan; Crabb Lesley; Pavese Nicola; Oertel Wolfgang H; Quinn Niall; Brooks David J; Lindvall Olle
Dyskinesias following neural transplantation in Parkinson's disease.
Nature neuroscience 2002;5(7):627-8.
2002: Ito Kengo; Nagano-Saito Atsuko; Kato Takashi; Arahata Yutaka; Nakamura Akinori; Kawasumi Yasuhiro; Hatano Kentaro; Abe Yuji; Yamada Takako; Kachi Teruhiko; Brooks David J
Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study.
Brain : a journal of neurology 2002;125(Pt 6):1358-65.
2002: Brunt E R; Brooks D J; Korczyn A D; Montastruc J-L; Stocchi F;
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(4):489-502.
2002: Brooks David J
Diagnosis and management of atypical parkinsonian syndromes.
Journal of neurology, neurosurgery, and psychiatry 2002;72 Suppl 1():I10-I16.
2002: Hammers Alexander; Koepp Matthias J; Free Samantha L; Brett Matthew; Richardson Mark P; Labbé Claire; Cunningham Vincent J; Brooks David J; Duncan John
Implementation and application of a brain template for multiple volumes of interest.
Human brain mapping 2002;15(3):165-74.
2002: Ceravolo Roberto; Piccini Paola; Bailey Dale L; Jorga Karin M; Bryson Helen; Brooks David J
18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease.
Synapse (New York, N.Y.) 2002;43(3):201-7.
2002: Nicholl D J; Vaughan J R; Khan N L; Ho S L; Aldous D E W; Lincoln S; Farrer M; Gayton J D; Davis M B; Piccini P; Daniel S E; Lennox G G; Brooks D J; Williams A C; Wood N W
Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic study.
Brain : a journal of neurology 2002;125(Pt 1):44-57.
2002: Leigh P Nigel; Simmons Andrew; Williams Steve; Williams Vicky; Turner Martin; Brooks David
Imaging: MRS/MRI/PET/SPECT: summary.
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 2002;3 Suppl 1():S75-80.
2001: Hirani E; Gillies J; Karasawa A; Shimada J; Kase H; Opacka-Juffry J; Osman S; Luthra S K; Hume S P; Brooks D J
Evaluation of [4-O-methyl-(11)C]KW-6002 as a potential PET ligand for mapping central adenosine A(2A) receptors in rats.
Synapse (New York, N.Y.) 2001;42(3):164-76.
2001: Berding G; Odin P; Brooks D J; Nikkhah G; Matthies C; Peschel T; Shing M; Kolbe H; van Den Hoff J; Fricke H; Dengler R; Samii M; Knapp W H
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
Movement disorders : official journal of the Movement Disorder Society 2001;16(6):1014-22.
2001: Banati R B; Cagnin A; Brooks D J; Gunn R N; Myers R; Jones T; Birch R; Anand P
Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury.
Neuroreport 2001;12(16):3439-42.
2001: Piccini P; de Yebenez J; Lees A J; Ceravolo R; Turjanski N; Pramstaller P; Brooks D J
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Archives of neurology 2001;58(11):1846-51.
2001: Richardson M P; Hammers A; Brooks D J; Duncan J S
Benzodiazepine-GABA(A) receptor binding is very low in dysembryoplastic neuroepithelial tumor: a PET study.
Epilepsia 2001;42(10):1327-34.
2001: Bhatia K; Brooks D J; Burn D J; Clarke C E; Grosset D G; MacMahon D G; Playfer J; Schapira A H; Stewart D; Williams A C;
Updated guidelines for the management of Parkinson's disease.
Hospital medicine (London, England : 1998) 2001;62(8):456-70.
2001: Cagnin A; Brooks D J; Kennedy A M; Gunn R N; Myers R; Turkheimer F E; Jones T; Banati R B
In-vivo measurement of activated microglia in dementia.
Lancet 2001;358(9280):461-7.
2001: Brooks D J; Doder M
Depression in Parkinson's disease.
Current opinion in neurology 2001;14(4):465-70.
2001: Hammers A; Koepp M J; Richardson M P; Labbé C; Brooks D J; Cunningham V J; Duncan J S
Central benzodiazepine receptors in malformations of cortical development: A quantitative study.
Brain : a journal of neurology 2001;124(Pt 8):1555-65.
2001: Hu M T; White S J; Herlihy A H; Chaudhuri K R; Hajnal J V; Brooks D J
A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease.
Neurology 2001;56(9):1195-200.
2001: Dagher A; Owen A M; Boecker H; Brooks D J
The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease.
Brain : a journal of neurology 2001;124(Pt 5):1020-32.
2001: Hammers A; Koepp M J; Labbé C; Brooks D J; Thom M; Cunningham V J; Duncan J S
Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy.
Neurology 2001;56(7):897-906.
2001: Samuel M; Ceballos-Baumann A O; Boecker H; Brooks D J
Motor imagery in normal subjects and Parkinson's disease patients: an H215O PET study.
Neuroreport 2001;12(4):821-8.
2001: Brooks D J
Functional imaging studies on dopamine and motor control.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(11):1283-98.
2001: Brooks D J
Cerebral blood flow activation studies in Parkinson's disease.
Advances in neurology 2001;86():225-35.
2001: Hu M T; White S J; Chaudhuri K R; Morris R G; Bydder G M; Brooks D J
Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.
Journal of neural transmission (Vienna, Austria : 1996) 2001;108(5):571-80.
2000: Piccini P; Lindvall O; Björklund A; Brundin P; Hagell P; Ceravolo R; Oertel W; Quinn N; Samuel M; Rehncrona S; Widner H; Brooks D J
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts.
Annals of neurology 2000;48(5):689-95.
2000: Lloyd C M; Richardson M P; Brooks D J; Al-Chalabi A; Leigh P N
Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil.
Brain : a journal of neurology 2000;123 ( Pt 11)():2289-96.
2000: Brooks D J
PET studies and motor complications in Parkinson's disease.
Trends in neurosciences 2000;23(10 Suppl):S101-8.
2000: White R P; Deane C; Hindley C; Bloomfield P M; Cunningham V J; Vallance P; Brooks D J; Markus H S
The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man.
Journal of the neurological sciences 2000;178(1):23-8.
2000: Capaday C; Richardson M P; Rothwell J C; Brooks D J
Long-term changes of GABAergic function in the sensorimotor cortex of amputees. A combined magnetic stimulation and 11C-flumazenil PET study.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 2000;133(4):552-6.
2000: Brundin P; Pogarell O; Hagell P; Piccini P; Widner H; Schrag A; Kupsch A; Crabb L; Odin P; Gustavii B; Björklund A; Brooks D J; Marsden C D; Oertel W H; Quinn N P; Rehncrona S; Lindvall O
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease.
Brain : a journal of neurology 2000;123 ( Pt 7)():1380-90.
2000: Jenkins I H; Jahanshahi M; Jueptner M; Passingham R E; Brooks D J
Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow.
Brain : a journal of neurology 2000;123 ( Pt 6)():1216-28.
2000: Brooks D J
Dopamine agonists: their role in the treatment of Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2000;68(6):685-9.
2000: Brooks D J
Imaging basal ganglia function.
Journal of anatomy 2000;196 ( Pt 4)():543-54.
2000: Litvan I; Dickson D W; Buttner-Ennever J A; Delacourte A; Hutton M; Dubois B; Golbe L I; Hallett M; Schellenberg G D; Standaert D; Brooks D J; Price D
Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP.
Movement disorders : official journal of the Movement Disorder Society 2000;15(3):446-58.
2000: Rascol O; Brooks D J; Korczyn A D; De Deyn P P; Clarke C E; Lang A E
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group.
The New England journal of medicine 2000;342(20):1484-91.
2000: Piccini P; Brooks D J; Korpela K; Pavese N; Karlsson M; Gordin A
The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2000;68(5):589-94.
2000: Brooks D J
Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease.
Journal of neurology 2000;247 Suppl 2():II11-8.
2000: Brooks D J; Forsyth D; Playfer J R; Williams A C
The role of entacapone in the management of Parkinson's disease.
Hospital medicine (London, England : 1998) 2000;61(4):267-71.
2000: Brooks D J; Piccini P; Turjanski N; Samuel M
Neuroimaging of dyskinesia.
Annals of neurology 2000;47(4 Suppl 1):S154-8; discussion S158-9.
2000: Jalan R; Turjanski N; Taylor-Robinson S D; Koepp M J; Richardson M P; Wilson J A; Bell J D; Brooks D J
Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis.
Gut 2000;46(4):546-52.
2000: Hagell P; Crabb L; Pogarell O; Schrag A; Widner H; Brooks D J; Oertel W H; Quinn N P; Lindvall O
Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2000;15(2):224-9.
2000: Hu M T; Taylor-Robinson S D; Chaudhuri K R; Bell J D; Labbé C; Cunningham V J; Koepp M J; Hammers A; Morris R G; Turjanski N; Brooks D J
Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.
Brain : a journal of neurology 2000;123 ( Pt 2)():340-52.
2000: Reuter I; Hu M T; Andrews T C; Brooks D J; Clough C; Chaudhuri K R
Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.
Journal of neurology, neurosurgery, and psychiatry 2000;68(2):238-41.
2000: Rogers R D; Andrews T C; Grasby P M; Brooks D J; Robbins T W
Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans.
Journal of cognitive neuroscience 2000;12(1):142-62.
2000: Koepp M J; Hammers A; Labbé C; Woermann F G; Brooks D J; Duncan J S
11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI.
Neurology 2000;54(2):332-9.
2000: Chaudhuri K R; Hu M T; Brooks D J
Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK.
Movement disorders : official journal of the Movement Disorder Society 2000;15(1):18-23.
2000: Brooks D J
Monitoring neuroprotection and restorative therapies in Parkinson's disease with PET.
Journal of neural transmission. Supplementum 2000;(60):125-37.
2000: Brooks D J; Samuel M
The effects of surgical treatment of Parkinson's disease on brain function: PET findings.
Neurology 2000;55(12 Suppl 6):S52-9.
2000: Brooks D J; Piccini P
Non-invasive in vivo imaging of transplant function.
Progress in brain research 2000;127():321-32.
2000: Brooks D J
Functional imaging studies in corticobasal degeneration.
Advances in neurology 2000;82():209-15.
1999: Banati R B; Goerres G W; Myers R; Gunn R N; Turkheimer F E; Kreutzberg G W; Brooks D J; Jones T; Duncan J S
[11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis.
Neurology 1999;53(9):2199-203.
1999: Andrews T C; Weeks R A; Turjanski N; Gunn R N; Watkins L H; Sahakian B; Hodges J R; Rosser A E; Wood N W; Brooks D J
Huntington's disease progression. PET and clinical observations.
Brain : a journal of neurology 1999;122 ( Pt 12)():2353-63.
1999: Piccini P; Brooks D J; Björklund A; Gunn R N; Grasby P M; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Nature neuroscience 1999;2(12):1137-40.
1999: Dagher A; Owen A M; Boecker H; Brooks D J
Mapping the network for planning: a correlational PET activation study with the Tower of London task.
Brain : a journal of neurology 1999;122 ( Pt 10)():1973-87.
1999: Schrag A; Samuel M; Caputo E; Scaravilli T; Troyer M; Marsden C D; Thomas D G; Lees A J; Brooks D J; Quinn N P
Unilateral pallidotomy for Parkinson's disease: results after more than 1 year.
Journal of neurology, neurosurgery, and psychiatry 1999;67(4):511-7.
1999: Rakshi J S; Uema T; Ito K; Bailey D L; Morrish P K; Ashburner J; Dagher A; Jenkins I H; Friston K J; Brooks D J
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.
Brain : a journal of neurology 1999;122 ( Pt 9)():1637-50.
1999: Hu M T; Taylor-Robinson S D; Chaudhuri K R; Bell J D; Morris R G; Clough C; Brooks D J; Turjanski N
Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study.
Journal of neurology, neurosurgery, and psychiatry 1999;67(1):20-6.
1999: White R P; Hindley C; Bloomfield P M; Cunningham V J; Vallance P; Brooks D J; Markus H S
The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: a PET study.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1999;19(6):673-8.
1999: Hagell P; Schrag A; Piccini P; Jahanshahi M; Brown R; Rehncrona S; Widner H; Brundin P; Rothwell J C; Odin P; Wenning G K; Morrish P; Gustavii B; Björklund A; Brooks D J; Marsden C D; Quinn N P; Lindvall O
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft.
Brain : a journal of neurology 1999;122 ( Pt 6)():1121-32.
1999: Ito K; Morrish P K; Rakshi J S; Uema T; Ashburner J; Bailey D L; Friston K J; Brooks D J
Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1999;66(6):754-8.
1999: Nicolson R I; Fawcett A J; Berry E L; Jenkins I H; Dean P; Brooks D J
Association of abnormal cerebellar activation with motor learning difficulties in dyslexic adults.
Lancet 1999;353(9165):1662-7.
1999: Piccini P; Burn D J; Ceravolo R; Maraganore D; Brooks D J
The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.
Annals of neurology 1999;45(5):577-82.
1999: Hamdy S; Rothwell J C; Brooks D J; Bailey D; Aziz Q; Thompson D G
Identification of the cerebral loci processing human swallowing with H2(15)O PET activation.
Journal of neurophysiology 1999;81(4):1917-26.
1999: Taylor-Robinson S D; Turjanski N; Bhattacharya S; Seery J P; Sargentoni J; Brooks D J; Bryant D J; Cox I J
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
Metabolic brain disease 1999;14(1):45-55.
1999: Turjanski N; Lees A J; Brooks D J
Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
Neurology 1999;52(5):932-7.
1999: Piccini P; Brooks D J
Etiology of Parkinson's disease: contributions from 18F-DOPA positron emission tomography.
Advances in neurology 1999;80():227-31.
1999: Kapur N; Brooks D J
Temporally-specific retrograde amnesia in two cases of discrete bilateral hippocampal pathology.
Hippocampus 1999;9(3):247-54.
1999: Brooks D J
Functional imaging of Parkinson's disease: is it possible to detect brain areas for specific symptoms?
Journal of neural transmission. Supplementum 1999;56():139-53.
1998: Andrews T C; Brooks D J
Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET.
Molecular medicine today 1998;4(12):532-9.
1998: Samuel M; Williams S C; Leigh P N; Simmons A; Chakraborti S; Andrew C M; Friston K J; Goldstein L H; Brooks D J
Exploring the temporal nature of hemodynamic responses of cortical motor areas using functional MRI.
Neurology 1998;51(6):1567-75.
1998: Goerres G W; Samuel M; Jenkins I H; Brooks D J
Cerebral control of unimanual and bimanual movements: an H2(15)O PET study.
Neuroreport 1998;9(16):3631-8.
1998: Koepp M J; Richardson M P; Brooks D J; Duncan J S
Focal cortical release of endogenous opioids during reading-induced seizures.
Lancet 1998;352(9132):952-5.
1998: Brooks D J
The early diagnosis of Parkinson's disease.
Annals of neurology 1998;44(3 Suppl 1):S10-8.
1998: Richardson M P; Koepp M J; Brooks D J; Duncan J S
11C-flumazenil PET in neocortical epilepsy.
Neurology 1998;51(2):485-92.
1998: Lawrence A D; Weeks R A; Brooks D J; Andrews T C; Watkins L H; Harding A E; Robbins T W; Sahakian B J
The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease.
Brain : a journal of neurology 1998;121 ( Pt 7)():1343-55.
1998: Richardson M P; Koepp M J; Brooks D J; Coull J T; Grasby P; Fish D R; Duncan J S
Cerebral activation in malformations of cortical development.
Brain : a journal of neurology 1998;121 ( Pt 7)():1295-304.
1998: Schrag A; Rinne J O; Burn D J; Mathias C J; Marsden C D; Brooks D J; Quinn N P
Olivopontocerebellar atrophy and multiple system atrophy: clinical follow-up of 10 patients studied with PET.
Annals of neurology 1998;44(1):151-2.
1998: Bhatia K; Brooks D J; Burn D J; Clarke C E; Playfer J; Sawle G V; Schapira A H; Stewart D; Williams A C
Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.
Hospital medicine (London, England : 1998) 1998;59(6):469-80.
1998: Schrag A E; Brooks D J; Brunt E; Fuell D; Korczyn A; Poewe W; Quinn N P; Rascol O; Stocchi F
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.
Clinical neuropharmacology 1998;21(3):169-75.
1998: Koepp M J; Gunn R N; Lawrence A D; Cunningham V J; Dagher A; Jones T; Brooks D J; Bench C J; Grasby P M
Evidence for striatal dopamine release during a video game.
Nature 1998;393(6682):266-8.
1998: Koepp M J; Hand K S; Labbé C; Richardson M P; Van Paesschen W; Baird V H; Cunningham V J; Bowery N G; Brooks D J; Duncan J S
In vivo [11C]flumazenil-PET correlates with ex vivo [3H]flumazenil autoradiography in hippocampal sclerosis.
Annals of neurology 1998;43(5):618-26.
1998: Spence S A; Hirsch S R; Brooks D J; Grasby P M
Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia.
The British journal of psychiatry : the journal of mental science 1998;172():316-23.
1998: Brooks D J
Positron emission tomography studies in movement disorders.
Neurosurgery clinics of North America 1998;9(2):263-82.
1998: Brooks D J; Abbott R J; Lees A J; Martignoni E; Philcox D V; Rascol O; Roos R A; Sagar H J
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.
Clinical neuropharmacology 1998;21(2):101-7.
1998: Playford E D; Passingham R E; Marsden C D; Brooks D J
Increased activation of frontal areas during arm movement in idiopathic torsion dystonia.
Movement disorders : official journal of the Movement Disorder Society 1998;13(2):309-18.
1998: Morrish P K; Rakshi J S; Bailey D L; Sawle G V; Brooks D J
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
Journal of neurology, neurosurgery, and psychiatry 1998;64(3):314-9.
1998: Koepp M J; Hansen M L; Pressler R M; Brooks D J; Brandl U; Guldin B; Duncan J S; Ried S
Comparison of EEG, MRI and PET in reading epilepsy: a case report.
Epilepsy research 1998;29(3):251-7.
1998: Boecker H; Dagher A; Ceballos-Baumann A O; Passingham R E; Samuel M; Friston K J; Poline J; Dettmers C; Conrad B; Brooks D J
Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: investigations with H2 15O PET.
Journal of neurophysiology 1998;79(2):1070-80.
1998: Samuel M; Caputo E; Brooks D J; Schrag A; Scaravilli T; Branston N M; Rothwell J C; Marsden C D; Thomas D G; Lees A J; Quinn N P
A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications.
Brain : a journal of neurology 1998;121 ( Pt 1)():59-75.
1998: Korczyn A D; Brooks D J; Brunt E R; Poewe W H; Rascol O; Stocchi F
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):46-51.
1998: Rascol O; Brooks D J; Brunt E R; Korczyn A D; Poewe W H; Stocchi F
Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):39-45.
1998: Boecker H; Brooks D J
Functional imaging of tremor.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 3():64-72.
1998: Ceballos-Baumann A O; Brooks D J
Activation positron emission tomography scanning in dystonia.
Advances in neurology 1998;78():135-52.
1997: Turjanski N; Pentland B; Lees A J; Brooks D J
Parkinsonism associated with acute intracranial hematomas: an [18F]dopa positron-emission tomography study.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):1035-8.
1997: Spence S A; Brooks D J; Hirsch S R; Liddle P F; Meehan J; Grasby P M
A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control).
Brain : a journal of neurology 1997;120 ( Pt 11)():1997-2011.
1997: Richardson M P; Friston K J; Sisodiya S M; Koepp M J; Ashburner J; Free S L; Brooks D J; Duncan J S
Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data.
Brain : a journal of neurology 1997;120 ( Pt 11)():1961-73.
1997: Piccini P; Weeks R A; Brooks D J
Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias.
Annals of neurology 1997;42(5):720-6.
1997: Koepp M J; Richardson M P; Brooks D J; Cunningham V J; Duncan J S
Central benzodiazepine/gamma-aminobutyric acid A receptors in idiopathic generalized epilepsy: an [11C]flumazenil positron emission tomography study.
Epilepsia 1997;38(10):1089-97.
1997: Koepp M J; Labbé C; Richardson M P; Brooks D J; Van Paesschen W; Cunningham V J; Duncan J S
Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis.
Brain : a journal of neurology 1997;120 ( Pt 10)():1865-76.
1997: Jenkins I H; Passingham R E; Brooks D J
The effect of movement frequency on cerebral activation: a positron emission tomography study.
Journal of the neurological sciences 1997;151(2):195-205.
1997: Nagahama Y; Fukuyama H; Turjanski N; Kennedy A; Yamauchi H; Ouchi Y; Kimura J; Brooks D J; Shibasaki H
Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):691-6.
1997: Weeks R A; Ceballos-Baumann A; Piccini P; Boecker H; Harding A E; Brooks D J
Cortical control of movement in Huntington's disease. A PET activation study.
Brain : a journal of neurology 1997;120 ( Pt 9)():1569-78.
1997: Weeks R A; Cunningham V J; Piccini P; Waters S; Harding A E; Brooks D J
11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1997;17(9):943-9.
1997: Koepp M J; Richardson M P; Labbé C; Brooks D J; Cunningham V J; Ashburner J; Van Paesschen W; Revesz T; Duncan J S
11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
Neurology 1997;49(3):764-73.
1997: Turjanski N; Lees A J; Brooks D J
In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias.
Neurology 1997;49(3):717-23.
1997: Samuel M; Ceballos-Baumann A O; Turjanski N; Boecker H; Gorospe A; Linazasoro G; Holmes A P; DeLong M R; Vitek J L; Thomas D G; Quinn N P; Obeso J A; Brooks D J
Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study.
Brain : a journal of neurology 1997;120 ( Pt 8)():1301-13.
1997: Brooks D J
Advances in imaging Parkinson's disease.
Current opinion in neurology 1997;10(4):327-31.
1997: Rabey J M; Bass H; Bonuccelli U; Brooks D; Klotz P; Korczyn A D; Kraus P; Martinez-Martin P; Morrish P; Van Sauten W; Van Hilten B
Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials.
Clinical neuropharmacology 1997;20(4):322-37.
1997: Fricker R A; Torres E M; Hume S P; Myers R; Opacka-Juffrey J; Ashworth S; Brooks D J; Dunnett S B
The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour.
Neuroscience 1997;79(3):711-21.
1997: Wenning G K; Odin P; Morrish P; Rehncrona S; Widner H; Brundin P; Rothwell J C; Brown R; Gustavii B; Hagell P; Jahanshahi M; Sawle G; Björklund A; Brooks D J; Marsden C D; Quinn N P; Lindvall O
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease.
Annals of neurology 1997;42(1):95-107.
1997: Turjanski N; Lees A J; Brooks D J
Dopaminergic function in patients with posttraumatic parkinsonism: an 18F-dopa PET study.
Neurology 1997;49(1):183-9.
1997: Samuel M; Ceballos-Baumann A O; Blin J; Uema T; Boecker H; Passingham R E; Brooks D J
Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study.
Brain : a journal of neurology 1997;120 ( Pt 6)():963-76.
1997: Kew J J; Halligan P W; Marshall J C; Passingham R E; Rothwell J C; Ridding M C; Marsden C D; Brooks D J
Abnormal access of axial vibrotactile input to deafferented somatosensory cortex in human upper limb amputees.
Journal of neurophysiology 1997;77(5):2753-64.
1997: Abrahams S; Goldstein L H; Al-Chalabi A; Pickering A; Morris R G; Passingham R E; Brooks D J; Leigh P N
Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1997;62(5):464-72.
1997: Brooks D J
PET and SPECT studies in Parkinson's disease.
Baillière's clinical neurology 1997;6(1):69-87.
1997: Ceballos-Baumann A O; Sheean G; Passingham R E; Marsden C D; Brooks D J
Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study.
Brain : a journal of neurology 1997;120 ( Pt 4)():571-82.
1997: Jueptner M; Frith C D; Brooks D J; Frackowiak R S; Passingham R E
Anatomy of motor learning. II. Subcortical structures and learning by trial and error.
Journal of neurophysiology 1997;77(3):1325-37.
1997: Jueptner M; Stephan K M; Frith C D; Brooks D J; Frackowiak R S; Passingham R E
Anatomy of motor learning. I. Frontal cortex and attention to action.
Journal of neurophysiology 1997;77(3):1313-24.
1997: Piccini P; Morrish P K; Turjanski N; Sawle G V; Burn D J; Weeks R A; Mark M H; Maraganore D M; Lees A J; Brooks D J
Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study.
Annals of neurology 1997;41(2):222-9.
1997: Chaudhuri K R; Richards M; Brooks D J
How far are we in understanding the cause of Parkinson's disease?
Journal of neurology, neurosurgery, and psychiatry 1997;62(1):104.
1997: Boecker H; Wills A J; Ceballos-Baumann A; Samuel M; Thomas D G; Marsden C D; Brooks D J
Stereotactic thalamotomy in tremor-dominant Parkinson's disease: an H2(15)O PET motor activation study.
Annals of neurology 1997;41(1):108-11.
1997: Turjanski N; Brooks D J
PET and the investigation of dementia in the parkinsonian patient.
Journal of neural transmission. Supplementum 1997;51():37-48.
1997: Brooks D J
Motor disturbance and brain functional imaging in Parkinson's disease.
European neurology 1997;38 Suppl 2():26-32.
1997: Ceballos-Baumann A O; Brooks D J
Basal ganglia function and dysfunction revealed by PET activation studies.
Advances in neurology 1997;74():127-39.
1996: Abrahams S; Goldstein L H; Kew J J; Brooks D J; Lloyd C M; Frith C D; Leigh P N
Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study.
Brain : a journal of neurology 1996;119 ( Pt 6)():2105-20.
1996: Morrish P K; Sawle G V; Brooks D J
Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.
Brain : a journal of neurology 1996;119 ( Pt 6)():2097-103.
1996: Jueptner M; Jenkins I H; Brooks D J; Frackowiak R S; Passingham R E
The sensory guidance of movement: a comparison of the cerebellum and basal ganglia.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1996;112(3):462-74.
1996: Kling P J; Dragsten P R; Roberts R A; Dos Santos B; Brooks D J; Hedlund B E; Taetle R
Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancy.
British journal of haematology 1996;95(2):241-8.
1996: Koepp M J; Richardson M P; Brooks D J; Poline J B; Van Paesschen W; Friston K J; Duncan J S
Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis.
Brain : a journal of neurology 1996;119 ( Pt 5)():1677-87.
1996: Richardson M P; Koepp M J; Brooks D J; Fish D R; Duncan J S
Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study.
Annals of neurology 1996;40(2):188-98.
1996: Weeks R A; Piccini P; Harding A E; Brooks D J
Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease.
Annals of neurology 1996;40(1):49-54.
1996: Weeks R A; Turjanski N; Brooks D J
Tourette's syndrome: a disorder of cingulate and orbitofrontal function?
QJM : monthly journal of the Association of Physicians 1996;89(6):401-8.
1996: Bain P G; Britton T C; Jenkins I H; Thompson P D; Rothwell J C; Thomas P K; Brooks D J; Marsden C D
Tremor associated with benign IgM paraproteinaemic neuropathy.
Brain : a journal of neurology 1996;119 ( Pt 3)():789-99.
1996: Boecker H; Wills A J; Ceballos-Baumann A; Samuel M; Thompson P D; Findley L J; Brooks D J
The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study.
Annals of neurology 1996;39(5):650-8.
1996: Morrish P K; Sawle G V; Brooks D J
An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.
Brain : a journal of neurology 1996;119 ( Pt 2)():585-91.
1996: Hume S P; Luthra S K; Brown D J; Opacka-Juffry J; Osman S; Ashworth S; Myers R; Brady F; Carroll F I; Kuhar M J; Brooks D J
Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter.
Nuclear medicine and biology 1996;23(3):377-84.
1996: Taylor-Robinson S D; Weeks R A; Bryant D J; Sargentoni J; Marcus C D; Harding A E; Brooks D J
Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory.
Movement disorders : official journal of the Movement Disorder Society 1996;11(2):167-73.
1996: Wills A J; Thompson P D; Findley L J; Brooks D J
A positron emission tomography study of primary orthostatic tremor.
Neurology 1996;46(3):747-52.
1996: Bhatia K P; Turjanski N; Brooks D J; Marsden C D; Thrush D
The usefulness of functional imaging in movement disorders: an illustrative case.
Journal of neurology, neurosurgery, and psychiatry 1996;60(3):353-4.
1996: Lammertsma A A; Bench C J; Hume S P; Osman S; Gunn K; Brooks D J; Frackowiak R S
Comparison of methods for analysis of clinical [11C]raclopride studies.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1996;16(1):42-52.
1996: Brooks D J
Functional imaging techniques in the diagnosis of non-Alzheimer dementias.
Journal of neural transmission. Supplementum 1996;47():155-67.
1996: Brooks D J
Basal ganglia function during normal and parkinsonian movement. PET activation studies.
Advances in neurology 1996;69():433-41.
1996: Morrish P K; Sawle G V; Brooks D J
The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study.
Advances in neurology 1996;69():427-31.
1995: Opacka-Juffry J; Ashworth S; Hume S P; Martin D; Brooks D J; Blunt S B
GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.
Neuroreport 1995;7(1):348-52.
1995: Morrish P K; Sawle G V; Brooks D J
Clinical and [18F] dopa PET findings in early Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1995;59(6):597-600.
1995: Haaxma R; van Boxtel A; Brouwer W H; Goeken L N; Denier van der Gon J J; Colebatch J G; Martin A; Brooks D J; Noth J; Marsden C D
Motor function in a patient with bilateral lesions of the globus pallidus.
Movement disorders : official journal of the Movement Disorder Society 1995;10(6):761-77.
1995: O'Sullivan E P; Jenkins I H; Henderson L; Kennard C; Brooks D J
The functional anatomy of remembered saccades: a PET study.
Neuroreport 1995;6(16):2141-4.
1995: Torres E M; Fricker R A; Hume S P; Myers R; Opacka-Juffry J; Ashworth S; Brooks D J; Dunnett S B
Assessment of striatal graft viability in the rat in vivo using a small diameter PET scanner.
Neuroreport 1995;6(15):2017-21.
1995: Ahmedzai S; Brooks D J
Treatment for cancer pain.
BMJ (Clinical research ed.) 1995;311(7010):951.
1995: Hume S P; Opacka-Juffry J; Myers R; Ahier R G; Ashworth S; Brooks D J; Lammertsma A A
Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET.
Synapse (New York, N.Y.) 1995;21(1):45-53.
1995: Burn D J; Rinne J O; Quinn N P; Lees A J; Marsden C D; Brooks D J
Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.
Brain : a journal of neurology 1995;118 ( Pt 4)():951-8.
1995: Jahanshahi M; Jenkins I H; Brown R G; Marsden C D; Passingham R E; Brooks D J
Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects.
Brain : a journal of neurology 1995;118 ( Pt 4)():913-33.
1995: Dettmers C; Fink G R; Lemon R N; Stephan K M; Passingham R E; Silbersweig D; Holmes A; Ridding M C; Brooks D J; Frackowiak R S
Relation between cerebral activity and force in the motor areas of the human brain.
Journal of neurophysiology 1995;74(2):802-15.
1995: Prevett M C; Duncan J S; Jones T; Fish D R; Brooks D J
Demonstration of thalamic activation during typical absence seizures using H2(15)O and PET.
Neurology 1995;45(7):1396-402.
1995: Brooks D J; Gamble W; Ahmedzai S
A regional survey of opioid use by patients receiving specialist palliative care.
Palliative medicine 1995;9(3):229-38.
1995: Ceballos-Baumann A O; Passingham R E; Marsden C D; Brooks D J
Motor reorganization in acquired hemidystonia.
Annals of neurology 1995;37(6):746-57.
1995: Turjanski N; Weeks R; Dolan R; Harding A E; Brooks D J
Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study.
Brain : a journal of neurology 1995;118 ( Pt 3)():689-96.
1995: Prevett M C; Lammertsma A A; Brooks D J; Cunningham V J; Fish D R; Duncan J S
Benzodiazepine-GABAA receptor binding during absence seizures.
Epilepsia 1995;36(6):592-9.
1995: Rinne J O; Burn D J; Mathias C J; Quinn N P; Marsden C D; Brooks D J
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy.
Annals of neurology 1995;37(5):568-73.
1995: Opacka-Juffry J; Brooks D J
L-dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):241-9.
1995: Abrahams S; Goldstein L H; Lloyd C M; Brooks D J; Leigh P N
Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: a neuropsychological investigation.
Journal of the neurological sciences 1995;129 Suppl():54-5.
1995: Abrahams S; Leigh P N; Kew J J; Goldstein L H; Lloyd C M; Brooks D J
A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis.
Journal of the neurological sciences 1995;129 Suppl():44-6.
1995: Playford E D; Britton T C; Thompson P D; Brooks D J; Findley L J; Marsden C D
Exacerbation of postural tremor with emergence of parkinsonism after treatment with neuroleptic drugs.
Journal of neurology, neurosurgery, and psychiatry 1995;58(4):487-9.
1995: Wills A J; Jenkins I H; Thompson P D; Findley L J; Brooks D J
A positron emission tomography study of cerebral activation associated with essential and writing tremor.
Archives of neurology 1995;52(3):299-305.
1995: Ceballos-Baumann A O; Passingham R E; Warner T; Playford E D; Marsden C D; Brooks D J
Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia.
Annals of neurology 1995;37(3):363-72.
1995: Prevett M C; Lammertsma A A; Brooks D J; Bartenstein P A; Patsalos P N; Fish D R; Duncan J S
Benzodiazepine-GABAA receptors in idiopathic generalized epilepsy measured with [11C]flumazenil and positron emission tomography.
Epilepsia 1995;36(2):113-21.
1995: Brooks D J
Parkinson's disease--a single clinical entity?
QJM : monthly journal of the Association of Physicians 1995;88(2):81-91.
1995: Brooks D J
The role of the basal ganglia in motor control: contributions from PET.
Journal of the neurological sciences 1995;128(1):1-13.
1995: Brooks D J; Torjanski N; Burn D J
Ropinirole in the symptomatic treatment of Parkinson's disease.
Journal of neural transmission. Supplementum 1995;45():231-8.
1995: Piccini P; Turjanski N; Brooks D J
PET studies of the striatal dopaminergic system in Parkinson's disease (PD).
Journal of neural transmission. Supplementum 1995;45():123-31.
1995: Menza M A; Mark M H; Burn D J; Brooks D J
Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences 1995;7(2):176-9.
1994: Kew J J; Ridding M C; Rothwell J C; Passingham R E; Leigh P N; Sooriakumaran S; Frackowiak R S; Brooks D J
Reorganization of cortical blood flow and transcranial magnetic stimulation maps in human subjects after upper limb amputation.
Journal of neurophysiology 1994;72(5):2517-24.
1994: Anderson T J; Jenkins I H; Brooks D J; Hawken M B; Frackowiak R S; Kennard C
Cortical control of saccades and fixation in man. A PET study.
Brain : a journal of neurology 1994;117 ( Pt 5)():1073-84.
1994: Wills A J; Jenkins I H; Thompson P D; Findley L J; Brooks D J
Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study.
Annals of neurology 1994;36(4):636-42.
1994: Ring H A; Bench C J; Trimble M R; Brooks D J; Frackowiak R S; Dolan R J
Depression in Parkinson's disease. A positron emission study.
The British journal of psychiatry : the journal of mental science 1994;165(3):333-9.
1994: Ceballos-Baumann A O; Obeso J A; Vitek J L; Delong M R; Bakay R; Linazasoro G; Brooks D J
Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease.
Lancet 1994;344(8925):814.
1994: Prevett M C; Cunningham V J; Brooks D J; Fish D R; Duncan J S
Opiate receptors in idiopathic generalised epilepsy measured with [11C]diprenorphine and positron emission tomography.
Epilepsy research 1994;19(1):71-7.
1994: Sawle G V; Burn D J; Morrish P K; Lammertsma A A; Snow B J; Luthra S; Osman S; Brooks D J
The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease.
Neurology 1994;44(7):1292-7.
1994: Kew J J; Brooks D J; Rassingham R E; Rothwell J C; Frackowiak R S; Leigh P N
Cortical function in progressive muscular atrophy and amyotrophic lateral sclerosis.
Journal of the neurological sciences 1994;124 Suppl():72.
1994: Kew J J; Brooks D J; Passingham R E; Rothwell J C; Frackowiak R S; Leigh P N
Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis: a comparative PET study.
Neurology 1994;44(6):1101-10.
1994: Jenkins I H; Brooks D J; Nixon P D; Frackowiak R S; Passingham R E
Motor sequence learning: a study with positron emission tomography.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1994;14(6):3775-90.
1994: Turjanski N; Sawle G V; Playford E D; Weeks R; Lammerstma A A; Lees A J; Brooks D J
PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.
Journal of neurology, neurosurgery, and psychiatry 1994;57(6):688-92.
1994: Taylor-Robinson S D; Weeks R A; Sargentoni J; Marcus C D; Bryant D J; Harding A E; Brooks D J
Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy.
Lancet 1994;343(8906):1170.
1994: Weeks R A; Lees A J; Brooks D J
Tourette's syndrome and the opioid system.
Lancet 1994;343(8905):1107-8.
1994: Burn D J; Sawle G V; Brooks D J
Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
Journal of neurology, neurosurgery, and psychiatry 1994;57(3):278-84.
1994: Sawle G V; Playford E D; Burn D J; Cunningham V J; Brooks D J
Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.
Archives of neurology 1994;51(3):237-43.
1994: Dexter D T; Brooks D J; Harding A E; Burn D J; Muller D P; Goss-Sampson M A; Jenner P G; Marsden C D
Nigrostriatal function in vitamin E deficiency: clinical, experimental, and positron emission tomographic studies.
Annals of neurology 1994;35(3):298-303.
1994: Lindvall O; Sawle G; Widner H; Rothwell J C; Björklund A; Brooks D; Brundin P; Frackowiak R; Marsden C D; Odin P
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease.
Annals of neurology 1994;35(2):172-80.
1994: Blunt S B; Brooks D J; Kennard C
Steroid-responsive chorea in childhood following cardiac transplantation.
Movement disorders : official journal of the Movement Disorder Society 1994;9(1):112-4.
1994: Brooks D J
PET studies in progressive supranuclear palsy.
Journal of neural transmission. Supplementum 1994;42():119-34.
1994: Weeks R A; Brooks D J
Positron emission tomography and central neurotransmitter systems in movement disorders.
Fundamental & clinical pharmacology 1994;8(6):503-17.
1993: Kew J J; Goldstein L H; Leigh P N; Abrahams S; Cosgrave N; Passingham R E; Frackowiak R S; Brooks D J
The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.
Brain : a journal of neurology 1993;116 ( Pt 6)():1399-423.
1993: Bartenstein P A; Duncan J S; Prevett M C; Cunningham V J; Fish D R; Jones A K; Luthra S K; Sawle G V; Brooks D J
Investigation of the opioid system in absence seizures with positron emission tomography.
Journal of neurology, neurosurgery, and psychiatry 1993;56(12):1295-302.
1993: Brooks D J
PET studies on the early and differential diagnosis of Parkinson's disease.
Neurology 1993;43(12 Suppl 6):S6-16.
1993: Playford E D; Fletcher N A; Sawle G V; Marsden C D; Brooks D J
Striatal [18F]dopa uptake in familial idiopathic dystonia.
Brain : a journal of neurology 1993;116 ( Pt 5)():1191-9.
1993: Vidailhet M; Stocchi F; Rothwell J C; Thompson P D; Day B L; Brooks D J; Marsden C D
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease.
Neurology 1993;43(9):1784-8.
1993: Sawle G V; Lees A J; Hymas N F; Brooks D J; Frackowiak R S
The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome.
Journal of neurology, neurosurgery, and psychiatry 1993;56(9):1016-9.
1993: Sawle G V; Playford E D; Brooks D J; Quinn N; Frackowiak R S
Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.
Brain : a journal of neurology 1993;116 ( Pt 4)():853-67.
1993: Turjanski N; Bhatia K; Burn D J; Sawle G V; Marsden C D; Brooks D J
Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
Neurology 1993;43(8):1563-8.
1993: Jenkins I H; Bain P G; Colebatch J G; Thompson P D; Findley L J; Frackowiak R S; Marsden C D; Brooks D J
A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections.
Annals of neurology 1993;34(1):82-90.
1993: Kew J J; Leigh P N; Playford E D; Passingham R E; Goldstein L H; Frackowiak R S; Brooks D J
Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study.
Brain : a journal of neurology 1993;116 ( Pt 3)():655-80.
1993: Brooks D J
Functional imaging in relation to parkinsonian syndromes.
Journal of the neurological sciences 1993;115(1):1-17.
1993: Burn D J; Brooks D J
Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.
Neurology 1993;43(3 Pt 1):552-6.
1993: Playford E D; Jenkins I H; Passingham R E; Frackowiak R S; Brooks D J
Impaired activation of frontal areas during movement in Parkinson's disease: a PET study.
Advances in neurology 1993;60():506-10.
1992: Jenkins I H; Fernandez W; Playford E D; Lees A J; Frackowiak R S; Passingham R E; Brooks D J
Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine.
Annals of neurology 1992;32(6):749-57.
1992: Sawle G V; Wroe S J; Lees A J; Brooks D J; Frackowiak R S
The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred.
Annals of neurology 1992;32(5):609-17.
1992: Burn D J; Mark M H; Playford E D; Maraganore D M; Zimmerman T R; Duvoisin R C; Harding A E; Marsden C D; Brooks D J
Parkinson's disease in twins studied with 18F-dopa and positron emission tomography.
Neurology 1992;42(10):1894-900.
1992: Hume S P; Myers R; Bloomfield P M; Opacka-Juffry J; Cremer J E; Ahier R G; Luthra S K; Brooks D J; Lammertsma A A
Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography.
Synapse (New York, N.Y.) 1992;12(1):47-54.
1992: Brooks D J; Playford E D; Ibanez V; Sawle G V; Thompson P D; Findley L J; Marsden C D
Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study.
Neurology 1992;42(8):1554-60.
1992: Playford E D; Jenkins I H; Passingham R E; Nutt J; Frackowiak R S; Brooks D J
Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.
Annals of neurology 1992;32(2):151-61.
1992: Sawle G V; Brooks D J
Normal aging of the nervous system.
Annals of neurology 1992;31(5):575-7.
1992: Brooks D J; Ibanez V; Sawle G V; Playford E D; Quinn N; Mathias C J; Lees A J; Marsden C D; Bannister R; Frackowiak R S
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Annals of neurology 1992;31(2):184-92.
1992: Sawle G V; Bloomfield P M; Björklund A; Brooks D J; Brundin P; Leenders K L; Lindvall O; Marsden C D; Rehncrona S; Widner H
Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
Annals of neurology 1992;31(2):166-73.
1992: Salmon E; Brooks D J
In vivo distribution of catecholamine reuptake sites in human brain gives clues to the physiopathology of MPTP-induced parkinsonism.
Journal of neurology, neurosurgery, and psychiatry 1992;55(2):167.
1992: Playford E D; Brooks D J
In vivo and in vitro studies of the dopaminergic system in movement disorders.
Cerebrovascular and brain metabolism reviews 1992;4(2):144-71.
1992: Brooks D J; Turjanski N; Sawle G V; Playford E D; Lees A J
PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome.
Advances in neurology 1992;58():227-31.
1991: Johnston S R; Burn D; Brooks D J
Peripheral neuropathy associated with lithium toxicity.
Journal of neurology, neurosurgery, and psychiatry 1991;54(11):1019-20.
1991: Brooks D J
Detection of preclinical Parkinson's disease with PET.
Geriatrics 1991;46 Suppl 1():25-30.
1991: Brooks D J; Ibanez V; Playford E D; Sawle G V; Leigh P N; Kocen R S; Harding A E; Marsden C D
Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study.
Annals of neurology 1991;30(2):166-71.
1991: Sawle G V; Leenders K L; Brooks D J; Harwood G; Lees A J; Frackowiak R S; Marsden C D
Dopa-responsive dystonia: [18F]dopa positron emission tomography.
Annals of neurology 1991;30(1):24-30.
1991: Brooks D J
Detection of preclinical Parkinson's disease with PET.
Neurology 1991;41(5 Suppl 2):24-7; discussion 28.
1991: Sawle G V; Brooks D J; Marsden C D; Frackowiak R S
Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography.
Brain : a journal of neurology 1991;114 ( Pt 1B)():541-56.
1991: Fearnley J M; Revesz T; Brooks D J; Frackowiak R S; Lees A J
Diffuse Lewy body disease presenting with a supranuclear gaze palsy.
Journal of neurology, neurosurgery, and psychiatry 1991;54(2):159-61.
1991: Chollet F; DiPiero V; Wise R J; Brooks D J; Dolan R J; Frackowiak R S
The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography.
Annals of neurology 1991;29(1):63-71.
1991: Brooks D J
The clinical role of PET in cerebrovascular disease.
Neurosurgical review 1991;14(2):91-6.
1990: Sawle G V; Colebatch J G; Shah A; Brooks D J; Marsden C D; Frackowiak R S
Striatal function in normal aging: implications for Parkinson's disease.
Annals of neurology 1990;28(6):799-804.
1990: Leenders K L; Salmon E P; Tyrrell P; Perani D; Brooks D J; Sager H; Jones T; Marsden C D; Frackowiak R S
The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.
Archives of neurology 1990;47(12):1290-8.
1990: Sawle G V; Brooks D J
Positron emission tomography studies of neurotransmitter systems.
Journal of neurology 1990;237(8):451-6.
1990: Brooks D J; Ibanez V; Sawle G V; Quinn N; Lees A J; Mathias C J; Bannister R; Marsden C D; Frackowiak R S
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Annals of neurology 1990;28(4):547-55.
1990: Brooks D J; Salmon E P; Mathias C J; Quinn N; Leenders K L; Bannister R; Marsden C D; Frackowiak R S
The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brain : a journal of neurology 1990;113 ( Pt 5)():1539-52.
1990: Colebatch J G; Findley L J; Frackowiak R S; Marsden C D; Brooks D J
Preliminary report: activation of the cerebellum in essential tremor.
Lancet 1990;336(8722):1028-30.
1990: Salmon E; Brooks D J; Leenders K L; Turton D R; Hume S P; Cremer J E; Jones T; Frackowiak R S
A two-compartment description and kinetic procedure for measuring regional cerebral [11C]nomifensine uptake using positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1990;10(3):307-16.
1989: Brooks D J
Positron emission tomographic studies of the subcortical degenerations and dystonia.
Seminars in neurology 1989;9(4):351-9.
1989: Godlee F N; Brooks D J; Impallomeni M
Dyskinesia in the elderly presenting as respiratory disorder.
Postgraduate medical journal 1989;65(769):830-1.
1989: Brooks D J; Redmond S; Mathias C J; Bannister R; Symon L
The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine.
Journal of neurology, neurosurgery, and psychiatry 1989;52(8):962-6.
1989: Brooks D J; Frackowiak R S
PET and movement disorders.
Journal of neurology, neurosurgery, and psychiatry 1989;Suppl():68-77.
1989: Wilcock G K; Hope R A; Brooks D N; Lantos P L; Oppenheimer C; Reynolds G P; Rossor M N; Davies M B
Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee.
Journal of neurology, neurosurgery, and psychiatry 1989;52(6):693-700.
1989: Brooks D J; Luthert P; Gadian D; Marsden C D
Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels.
Journal of neurology, neurosurgery, and psychiatry 1989;52(1):108-11.
1988: Fish D R; Brooks D J; Young I R; Bydder G M
Use of magnetic resonance imaging to identify changes in cerebral blood flow in epilepsia partialis continua.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1988;8(2):238-40.
1987: Fish D R; Lewis T T; Brooks D J; Zilkha E; Wise R J; Kendall B E
Regional cerebral blood flow of patients with focal epilepsy studied using xenon enhanced CT brain scanning.
Journal of neurology, neurosurgery, and psychiatry 1987;50(12):1584-8.
1987: Lammertsma A A; Brooks D J; Frackowiak R S; Beaney R P; Herold S; Heather J D; Palmer A J; Jones T
Measurement of glucose utilisation with [18F]2-fluoro-2-deoxy-D-glucose: a comparison of different analytical methods.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1987;7(2):161-72.
1987: Brooks D J; Carr D H; Legg N J
The role of delayed computed tomographic scanning using high doses of contrast material in detecting cerebral demyelination in patients with multiple sclerosis in relapse and remission.
The British journal of radiology 1987;60(711):295-7.
1987: Beaney R P; Leenders K L; Brooks D J
Effects of dexamethasone in brain tumour patients.
Lancet 1987;1(8532):571-2.
1987: Beaney R P; Gibbs J S; Brooks D J; McKenzie C G; Joplin G F; Jones T
Absence of irradiation induced ischaemic temporal lobe damage in patients with pituitary tumours.
Journal of neuro-oncology 1987;5(2):129-37.
1986: Speirs C J; Navey F L; Brooks D J; Impallomeni M G
Opisthotonos and benzodiazepine withdrawal in the elderly.
Lancet 1986;2(8515):1101.
1986: Brooks D J; Beaney R P; Thomas D G; Marshall J; Jones T
Studies on regional cerebral pH in patients with cerebral tumours using continuous inhalation of 11CO2 and positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1986;6(5):529-35.
1986: Brooks D J; Beaney R P; Powell M; Leenders K L; Crockard H A; Thomas D G; Marshall J; Jones T
Studies on cerebral oxygen metabolism, blood flow, and blood volume, in patients with hydrocephalus before and after surgical decompression, using positron emission tomography.
Brain : a journal of neurology 1986;109 ( Pt 4)():613-28.
1986: Brooks D J; Beaney R P; Lammertsma A A; Turton D R; Marshall J; Thomas D G; Jones T
Studies on regional cerebral haematocrit and blood flow in patients with cerebral tumours using positron emission tomography.
Microvascular research 1986;31(3):267-76.
1986: Brooks D J; Gibbs J S; Sharp P; Herold S; Turton D R; Luthra S K; Kohner E M; Bloom S R; Jones T
Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1986;6(2):240-4.
1986: Brooks D J; Frackowiak R S; Lammertsma A A; Herold S; Leenders K L; Selwyn A P; Turton D R; Brady F; Jones T
A comparison between regional cerebral blood flow measurements obtained in human subjects using 11C-methylalbumin microspheres, the C15O2 steady-state method, and positron emission tomography.
Acta neurologica Scandinavica 1986;73(4):415-22.
1986: Brooks D J; Beaney R P; Lammertsma A A; Herold S; Turton D R; Luthra S K; Frackowiak R S; Thomas D G; Marshall J; Jones T
Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1986;6(2):230-9.
1986: Brooks D J; Beaney R P; Thomas D G
The role of positron emission tomography in the study of cerebral tumors.
Seminars in oncology 1986;13(1):83-93.
1986: Leenders K L; Frackowiak R S; Quinn N; Brooks D; Sumner D; Marsden C D
Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning.
Movement disorders : official journal of the Movement Disorder Society 1986;1(1):51-8.
1985: Leenders K L; Beaney R P; Brooks D J; Lammertsma A A; Heather J D; McKenzie C G
Dexamethasone treatment of brain tumor patients: effects on regional cerebral blood flow, blood volume, and oxygen utilization.
Neurology 1985;35(11):1610-6.
1985: Brooks D J; Beaney R P; Leenders K L; Marshall J; Thomas D J; Jones T
Regional cerebral oxygen utilization, blood flow, and blood volume in benign intracranial hypertension studied by positron emission tomography.
Neurology 1985;35(7):1030-4.
1985: Beaney R P; Brooks D J; Leenders K L; Thomas D G; Jones T; Halnan K E
Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery.
Journal of neurology, neurosurgery, and psychiatry 1985;48(4):310-9.
1985: Thomas D G; Brooks D J; Beaney R P
Positron emission tomography in brain tumour imaging.
Progress in experimental tumor research. Fortschritte der experimentellen Tumorforschung. Progrès de la recherche expérimentale des tumeurs 1985;29():50-6.
1984: Lammertsma A A; Brooks D J; Frackowiak R S; Heather J D; Jones T
A method to quantitate the fractional extraction of rubidium-82 across the blood-brain barrier using positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1984;4(4):523-34.
1984: Brooks D J; Beaney R P; Lammertsma A A; Leenders K L; Horlock P L; Kensett M J; Marshall J; Thomas D G; Jones T
Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1984;4(4):535-45.
1984: Brooks D J; Leenders K L; Head G; Marshall J; Legg N J; Jones T
Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1984;47(11):1182-91.
1984: Brooks D J; Lammertsma A A; Beaney R P; Leenders K L; Buckingham P D; Marshall J; Jones T
Measurement of regional cerebral pH in human subjects using continuous inhalation of 11CO2 and positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1984;4(3):458-65.
1984: Lammertsma A A; Brooks D J; Beaney R P; Turton D R; Kensett M J; Heather J D; Marshall J; Jones T
In vivo measurement of regional cerebral haematocrit using positron emission tomography.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1984;4(3):317-22.
1984: Leenders K L; Herold S; Brooks D J; Palmer A J; Turton D; Firnau G; Garnett E S; Nahmias C; Veall N
Pre-synaptic and post-synaptic dopaminergic system in human brain.
Lancet 1984;2(8394):110-1.
1984: Thomas D G; Beaney R P; Brooks D J
Positron emission tomography in the study of cerebral tumours.
Neurosurgical review 1984;7(4):253-8.
1983: Brooks D J; Cant A J; Lambert H P; Wansbrough-Jones M H
Recurrent salmonella septicaemia with aortitis, osteomyelitis and psoas abscess.
The Journal of infection 1983;7(2):156-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

David Brooks

Research Profile (preview)

Procedures

Disorders

Anatomy

Chemicals & Drugs

Physiology

Concepts & Ideas

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of David Brooks (preview)

All Publications